Login / Signup

Safety and outcome of treatment of latent tuberculosis infection in liver transplant recipients.

Yun Woo LeeHyemin ChungSung Han KimHeung-Sup SungSu-Min HaEun-Kyoung JwaDong Hwan JungDeok Bog MoonSung Gyu LeeSang Oh Lee
Published in: Infection (2024)
These findings demonstrate that LTBI screening and treatment is a safe and effective strategy to prevent TB in LT recipients. However, monitoring for adverse events and liver enzyme elevation is recommended.
Keyphrases
  • mycobacterium tuberculosis
  • combination therapy
  • hepatitis c virus
  • human immunodeficiency virus
  • replacement therapy
  • drug induced